Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP
Both products will be manufactured at Lupin’s Pithampur facility in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin gets US FDA approval for Doxycycline Hyclate Delayed-Release Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin US FDA approval for Fluocinolone Acetonide Topical Oil
This product will be manufactured at Lupin’s Somerset facility in the US
Lupin gets US FDA approval for Norgestrel and Ethinyl Estradiol Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India.
Lupin announces resolution of USFDA warning letter for its two facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the warning letter that…
Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Lupin gets EIR from US FDA for Pithampur Unit-2 facility
The EIR was issued post the last inspection of the facility conducted from March 21-29, 2023
Lupin gets tentative US FDA approval for Dolutegravir Tablets for Oral Suspension
This product will be manufactured at Lupin’s Nagpur facility in India
Lupin receives USD 25 million from AbbVie for successful initiation of Phase 1 clinical studies
Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for this novel oncology drug to treat…